Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 881 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Seattle reports interim data from ADCETRIS CTCL trial

Case studies were also presented on two patients with relapsed peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS) who were treated with ADCETRIS. ADCETRIS is an antibody-drug conjugate (ADC) directed

Omnicell reports rise in Q4 revenues

The revenue for the quarter has witnessed a decline by $1.5m or 2.3% as compared to the third quarter of 2011. The revenue for the year ended 31